Download PDF
Thromb Haemost 1992; 68(04): 483-484
DOI: 10.1055/s-0038-1646304
Letters to the Editor
Schattauer GmbH Stuttgart

Venous Occlusion Does Not Induce the Release of Thrombomodulin from Endothelial Cells in Patients with Thromboembolic Disease

M C Alessi
*   Laboratory of Hematology CHU Timone, Marseille, France
,
M C Boffa
**   INSERM U150 Hôpital Saint Louis Paris, France
,
C Menart
*   Laboratory of Hematology CHU Timone, Marseille, France
,
M F Aillaud
*   Laboratory of Hematology CHU Timone, Marseille, France
,
G Parrot
*   Laboratory of Hematology CHU Timone, Marseille, France
,
I Juhan-Vague
*   Laboratory of Hematology CHU Timone, Marseille, France
› Author Affiliations
Further Information

Publication History

Received 24 January 1992

Accepted after revision 25 May 1992

Publication Date:
04 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • REFERENCES

  • 1 Esmon NL. Thrombomodulin. Prog Hemostas Thromb 1989; 9: 29-55
    PubMedGoogle Scholar
  • 2 Dittman WA, Majerus PW. Structure and function of thrombomodulin. Blood 1990; 2: 329-336
    PubMedGoogle Scholar
  • 3 Bourin MC, Lundgren-Akerlund E, Lindahl U. Isolation and characterization of the glycosaminoglycan component of rabbit thrombomodulin proteoglycan. J Biol Chem 1990; 265: 15424-15431
    PubMedGoogle Scholar
  • 4 Ishii H, Uchiyama H, Mutsuyosjhi K. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemostas 1991; 5: 618-623
    PubMedGoogle Scholar
  • 5 Yokohama N, Wada H, Shirakawa S, Koyama M, Hayashi T, Suzuki K. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Thromb Haemostas 1991; 6: 945 (Abstract)
    PubMedGoogle Scholar
  • 6 Ogawa S, Gerlach H, Esposito C, Pasagian-Macaulay A, Brett J, Stern D. Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J Clin Invest 1990; 4: 1090-1098
    PubMedGoogle Scholar
  • 7 Juhan-Vague I, Valadier J, Alessi MC, Aillaud MF, Ansaldi J, Philip-Joet C, Holvoet P, Serradimigni A, Collen D. Deficient t-PA released and elevated PA Inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemostas 1987; 57: 67-72
    PubMedGoogle Scholar
  • 8 Alessi MC, Juhan-Vague I, Declerck PJ, Anfosso F, Gueunoun E, Collen D. Correlations between t-PA and PAI-1 antigen and activity and t-PA/PAI-1 complexes in plasma of control subjects and of patients with increased t-PA or PAI-1 levels. Thromb Res 1991; 60: 509-516
    PubMedGoogle Scholar
  • 9 Jennings I, Luddington RJ, Harper PL. Changes in endothelial related coagulation proteins in response to venous occlusion. Thromb Haemostas 1991; 65: 374-376
    PubMedGoogle Scholar
  • 10 Amiral J, Canton M, Larrivaz I, Adam M, Boffa MC. Two-sites monoclonal ELISA for soluble forms of thrombomodulin. Blood 1991; 78 (Suppl 10) 69 (Abstract)
    PubMedGoogle Scholar
  • 11 Juhan-Vague I, Alessi MC, Joly P, Thirion X, Vague P, Declerck PJ, Serradimigni A, Collen D. Plasma plasminogen activator inhibitor 1 in angina pectoris. Influence of plasma insulin and acute-phase response. Arteriosclerosis 1989; 9: 362-367
    CrossrefPubMedGoogle Scholar